Hongze Chen

1.1k total citations
21 papers, 594 citations indexed

About

Hongze Chen is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Hongze Chen has authored 21 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Surgery and 9 papers in Oncology. Recurrent topics in Hongze Chen's work include Pancreatitis Pathology and Treatment (7 papers), Pancreatic and Hepatic Oncology Research (7 papers) and RNA modifications and cancer (6 papers). Hongze Chen is often cited by papers focused on Pancreatitis Pathology and Treatment (7 papers), Pancreatic and Hepatic Oncology Research (7 papers) and RNA modifications and cancer (6 papers). Hongze Chen collaborates with scholars based in China, United States and Japan. Hongze Chen's co-authors include Jisheng Hu, Bei Sun, Zhongjie Zhao, Chundong Cheng, Guanqun Li, Guangquan Zhang, Rui Kong, Wenbo Yang, Xinglong Geng and Yilong Li and has published in prestigious journals such as The FASEB Journal, Frontiers in Immunology and Molecular Cancer.

In The Last Decade

Hongze Chen

21 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongze Chen China 14 319 214 209 131 88 21 594
Zhongjie Zhao China 10 249 0.8× 160 0.7× 157 0.8× 58 0.4× 68 0.8× 15 427
Xiaopin Ji China 15 301 0.9× 183 0.9× 197 0.9× 105 0.8× 56 0.6× 31 584
Rahul Bhome United Kingdom 13 437 1.4× 341 1.6× 221 1.1× 58 0.4× 74 0.8× 29 743
Ram N. Trivedi United States 11 489 1.5× 131 0.6× 293 1.4× 167 1.3× 107 1.2× 19 800
Bei‐Ge Jiang China 15 308 1.0× 219 1.0× 135 0.6× 168 1.3× 73 0.8× 27 650
Satoe Fujiwara Japan 14 279 0.9× 169 0.8× 227 1.1× 89 0.7× 37 0.4× 38 677
Jiaxuan Chen China 12 260 0.8× 134 0.6× 143 0.7× 41 0.3× 101 1.1× 26 564
Patrick Tassone United States 14 251 0.8× 197 0.9× 194 0.9× 147 1.1× 38 0.4× 42 557
Zunqiang Xiao China 13 242 0.8× 205 1.0× 99 0.5× 82 0.6× 60 0.7× 33 512
Ahmed H. Mekkawy Australia 12 235 0.7× 146 0.7× 105 0.5× 72 0.5× 44 0.5× 27 466

Countries citing papers authored by Hongze Chen

Since Specialization
Citations

This map shows the geographic impact of Hongze Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongze Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongze Chen more than expected).

Fields of papers citing papers by Hongze Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongze Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongze Chen. The network helps show where Hongze Chen may publish in the future.

Co-authorship network of co-authors of Hongze Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Hongze Chen. A scholar is included among the top collaborators of Hongze Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongze Chen. Hongze Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Hongze, Muhammad Azhar Nisar, Xinjian Li, et al.. (2025). Liver TET1 promotes metabolic dysfunction-associated steatotic liver disease. EMBO Molecular Medicine. 17(5). 1101–1117. 1 indexed citations
2.
Zhang, Yangyang, Rui Kong, Wenbo Yang, et al.. (2023). DUSP2 recruits CSNK2A1 to suppress AKT1-mediated apoptosis resistance under hypoxic microenvironment in pancreatic cancer. Cancer Letters. 568. 216288–216288. 16 indexed citations
4.
Yang, Wenbo, Hongze Chen, Guanqun Li, et al.. (2023). Caprin-1 influences autophagy-induced tumor growth and immune modulation in pancreatic cancer. Journal of Translational Medicine. 21(1). 903–903. 8 indexed citations
5.
Nagaoka, Katsuya, Xuewei Bai, Dan Liŭ, et al.. (2023). Elevated 2-oxoglutarate antagonizes DNA damage responses in cholangiocarcinoma chemotherapy through regulating aspartate beta-hydroxylase. Cancer Letters. 580. 216493–216493. 4 indexed citations
6.
Zhao, Zhongjie, Wenbo Yang, Rui Kong, et al.. (2023). circEIF3I facilitates the recruitment of SMAD3 to early endosomes to promote TGF-β signalling pathway-mediated activation of MMPs in pancreatic cancer. Molecular Cancer. 22(1). 152–152. 22 indexed citations
7.
Cheng, Chundong, Mengyang Li, Bei Sun, et al.. (2022). Positive feedback regulation of lncRNA TPT1‐AS1 and ITGB3 promotes cell growth and metastasis in pancreatic cancer. Cancer Science. 113(9). 2986–3001. 18 indexed citations
8.
Zhang, Guangquan, Wenbo Yang, Hongze Chen, et al.. (2021). Lnc-PFAR facilitates autophagy and exacerbates pancreatic fibrosis by reducing pre-miR-141 maturation in chronic pancreatitis. Cell Death and Disease. 12(11). 996–996. 24 indexed citations
9.
Li, Guanqun, Hongze Chen, Liwei Liu, et al.. (2021). Role of Interleukin-17 in Acute Pancreatitis. Frontiers in Immunology. 12. 674803–674803. 25 indexed citations
10.
Geng, Xinglong, Hongze Chen, Liang Zhao, et al.. (2021). Cancer-Associated Fibroblast (CAF) Heterogeneity and Targeting Therapy of CAFs in Pancreatic Cancer. Frontiers in Cell and Developmental Biology. 9. 655152–655152. 133 indexed citations
11.
Zhang, Yang, Tao Zhang, Wenbo Yang, et al.. (2021). Beneficial Diets and Pancreatic Cancer: Molecular Mechanisms and Clinical Practice. Frontiers in Oncology. 11. 630972–630972. 5 indexed citations
12.
Chen, Hongze, Le Li, Jisheng Hu, et al.. (2019). UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1. Journal of Experimental & Clinical Cancer Research. 38(1). 297–297. 48 indexed citations
13.
Li, Le, Yue Yuan, Tao Zhang, et al.. (2019). HYAL‐1‐induced autophagy facilitates pancreatic fistula for patients who underwent pancreaticoduodenectomy. The FASEB Journal. 34(2). 2524–2540. 4 indexed citations
14.
Li, Yilong, Rui Kong, Hongze Chen, et al.. (2019). Overexpression of KLF5 is associated with poor survival and G1/S progression in pancreatic cancer. Aging. 11(14). 5035–5057. 32 indexed citations
15.
Zhang, Qi, Le Li, Hongze Chen, et al.. (2019). Soluble urokinase plasminogen activator receptor associates with higher risk, advanced disease severity as well as inflammation, and might serve as a prognostic biomarker of severe acute pancreatitis. Journal of Clinical Laboratory Analysis. 34(3). e23097–e23097. 12 indexed citations
16.
Hu, Jisheng, Le Li, Hongze Chen, et al.. (2018). MiR-361-3p regulates ERK1/2-induced EMT via DUSP2 mRNA degradation in pancreatic ductal adenocarcinoma. Cell Death and Disease. 9(8). 807–807. 68 indexed citations
19.
Li, Le, Gang Wang, Jisheng Hu, et al.. (2018). RB1CC1-enhanced autophagy facilitates PSCs activation and pancreatic fibrogenesis in chronic pancreatitis. Cell Death and Disease. 9(10). 952–952. 37 indexed citations
20.
Chen, Hongze, Liang Ji, Le Li, et al.. (2017). Early prediction of infected pancreatic necrosis secondary to necrotizing pancreatitis. Medicine. 96(30). e7487–e7487. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026